Literature DB >> 29873873

Change of sensing vector in the subcutaneous ICD during follow-up and after device replacement.

Markus Bettin1, Benjamin Rath1, Christian Ellermann1, Patrick Leitz1, Nils Bögeholz1, Florian Reinke1, Julia Köbe1, Lars Eckardt1, Gerrit Frommeyer1.   

Abstract

BACKGROUND: The subcutaneous implantable cardioverter defibrillator (S-ICD) has been established as a valuable alternative to transvenous ICD for prevention of sudden cardiac death. The system automatically chooses the optimal sensing vector. However, during follow-up and especially after device replacement we observed a change of the suggested sensing vector in automatic setup. Therefore, we analyzed frequency and reasons of vector change and its impact on inappropriate shocks (IAS).
MATERIAL AND METHODS: Between June 2010 and December 2017, a total of 216 patients with S-ICD® were included in this analysis. In all patients sensing vectors at the time of implantation, during follow-up, and after device replacement were investigated. Median follow-up time was 27.3 ± 25.3 months.
RESULTS: A change of the initial vector was seen in 77 patients (35.7%). The most frequent reason for vector change was the postoperative setup in supine and erect position in 54 patients (70.1%). In 12 patients (15.5%), the vector was manually changed due to inappropriate sensing and/or therapies. Routine setup during follow-up led to automatic vector change in 10 cases (13.0%). In only 1 patient the vector was manually changed due to oversensing in an exercise treadmill test. In 27 patients, the device was replaced due to battery depletion and in 6 of these patients the sensing vector was changed by the automatic setup. Vector change did not have an impact for inappropriate therapies in the follow-up; only 1 patient received an IAS due to an inadvertent vector change after device replacement.
CONCLUSION: In the present study, a significant number of S-ICD® patients had a manual or automatic vector change during follow-up and after device replacement. The study underlines the importance of a thoroughly performed screening and at least two valuable sensing vectors preimplant. Further studies are needed to evaluate the necessity of a routine automatic setup during follow-up.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  T-wave oversensing; device replacement; inappropriate shocks; subcutaneous ICD; sudden death

Mesh:

Year:  2018        PMID: 29873873     DOI: 10.1111/jce.13647

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  3 in total

Review 1.  [Subcutaneous implantable cardioverter-defibrillator : Current status and perspectives].

Authors:  Philipp Niehues; Gerrit Frommeyer; Florian Reinke; Lars Eckardt
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2018-10-10

2.  A sustained ventricular tachycardia overlooked by subcutaneous implantable cardioverter-defibrillator but recognized by co-implanted transvenous implantable cardioverter defibrillator.

Authors:  Kentaro Goto; Yuichi Ono; Yuki Osaka; Ken Kurihara; Kenichiro Otomo; Tetsuo Sasano
Journal:  HeartRhythm Case Rep       Date:  2020-03-08

3.  Lead-associated Superior Vena Cava Syndrome.

Authors:  Andrew H Locke; David J Shim; Jessica Burr; Tyler Mehegan; Kelsey Murphy; André D'Avila; Marc L Schermerhorn; Peter Zimetbaum
Journal:  J Innov Card Rhythm Manag       Date:  2021-04-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.